Koninklijke Philips N.V.
Koninklijke Philips N.V. RYLPF Peers
See (RYLPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RYLPF | $24.37 | +2.79% | 23.1B | 81.22 | $0.30 | +3.90% |
| SMMNY | $27.74 | +0.00% | 124B | 25.84 | $1.07 | +1.07% |
| SEMHF | $55.00 | +0.00% | 62.7B | 26.12 | $2.14 | +1.77% |
| SONVY | $59.71 | +0.00% | 18B | 27.29 | $2.21 | +1.05% |
| SONVF | $301.20 | +0.00% | 17.9B | 27.29 | $11.03 | +1.74% |
| SNNUF | $15.58 | +7.23% | 13.6B | 33.15 | $0.47 | +2.41% |
| CHEOY | $98.64 | +0.00% | 13.1B | 54.45 | $1.84 | +1.43% |
| CHEOF | $185.50 | -2.78% | 12.1B | 50.54 | $3.67 | +1.49% |
| WILYY | $21.31 | +0.00% | 9.2B | 21.09 | $1.02 | N/A |
| WILLF | $41.75 | +15.17% | 8.6B | 20.37 | $2.05 | N/A |
Stock Comparison
RYLPF vs SMMNY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SMMNY has a market cap of 124B. Regarding current trading prices, RYLPF is priced at $24.37, while SMMNY trades at $27.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SMMNY's P/E ratio is 25.84. In terms of profitability, RYLPF's ROE is +0.03%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, RYLPF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SEMHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SEMHF has a market cap of 62.7B. Regarding current trading prices, RYLPF is priced at $24.37, while SEMHF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SEMHF's P/E ratio is 26.12. In terms of profitability, RYLPF's ROE is +0.03%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, RYLPF and SEMHF have similar daily volatility (0.00).
RYLPF vs SONVY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SONVY has a market cap of 18B. Regarding current trading prices, RYLPF is priced at $24.37, while SONVY trades at $59.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SONVY's P/E ratio is 27.29. In terms of profitability, RYLPF's ROE is +0.03%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, RYLPF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SONVF has a market cap of 17.9B. Regarding current trading prices, RYLPF is priced at $24.37, while SONVF trades at $301.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SONVF's P/E ratio is 27.29. In terms of profitability, RYLPF's ROE is +0.03%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, RYLPF and SONVF have similar daily volatility (0.00).
RYLPF vs SNNUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SNNUF has a market cap of 13.6B. Regarding current trading prices, RYLPF is priced at $24.37, while SNNUF trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SNNUF's P/E ratio is 33.15. In terms of profitability, RYLPF's ROE is +0.03%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, RYLPF and SNNUF have similar daily volatility (0.00).
RYLPF vs CHEOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CHEOY has a market cap of 13.1B. Regarding current trading prices, RYLPF is priced at $24.37, while CHEOY trades at $98.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CHEOY's P/E ratio is 54.45. In terms of profitability, RYLPF's ROE is +0.03%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CHEOF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CHEOF has a market cap of 12.1B. Regarding current trading prices, RYLPF is priced at $24.37, while CHEOF trades at $185.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CHEOF's P/E ratio is 50.54. In terms of profitability, RYLPF's ROE is +0.03%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, RYLPF and CHEOF have similar daily volatility (0.00).
RYLPF vs WILYY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, WILYY has a market cap of 9.2B. Regarding current trading prices, RYLPF is priced at $24.37, while WILYY trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas WILYY's P/E ratio is 21.09. In terms of profitability, RYLPF's ROE is +0.03%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, RYLPF and WILYY have similar daily volatility (0.00).
RYLPF vs WILLF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, WILLF has a market cap of 8.6B. Regarding current trading prices, RYLPF is priced at $24.37, while WILLF trades at $41.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas WILLF's P/E ratio is 20.37. In terms of profitability, RYLPF's ROE is +0.03%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, RYLPF and WILLF have similar daily volatility (0.00).
RYLPF vs GNGBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, GNGBY has a market cap of 5.4B. Regarding current trading prices, RYLPF is priced at $24.37, while GNGBY trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas GNGBY's P/E ratio is 35.46. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNGBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, GNGBF has a market cap of 4.8B. Regarding current trading prices, RYLPF is priced at $24.37, while GNGBF trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas GNGBF's P/E ratio is 33.02. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, RYLPF and GNGBF have similar daily volatility (0.00).
RYLPF vs NHNKY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, NHNKY has a market cap of 4.4B. Regarding current trading prices, RYLPF is priced at $24.37, while NHNKY trades at $11.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas NHNKY's P/E ratio is 22.85. In terms of profitability, RYLPF's ROE is +0.03%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, RYLPF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMBBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, AMBBY has a market cap of 4.1B. Regarding current trading prices, RYLPF is priced at $24.37, while AMBBY trades at $15.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas AMBBY's P/E ratio is 74.57. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, RYLPF and AMBBY have similar daily volatility (0.00).
RYLPF vs AMBFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, AMBFF has a market cap of 4.1B. Regarding current trading prices, RYLPF is priced at $24.37, while AMBFF trades at $15.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas AMBFF's P/E ratio is 73.33. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, RYLPF and AMBFF have similar daily volatility (0.00).
RYLPF vs NHNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, RYLPF is priced at $24.37, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, RYLPF and NHNKF have similar daily volatility (0.00).
RYLPF vs GNNDY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, GNNDY has a market cap of 2.3B. Regarding current trading prices, RYLPF is priced at $24.37, while GNNDY trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas GNNDY's P/E ratio is 18.54. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs OSSFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, RYLPF is priced at $24.37, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, RYLPF and OSSFF have similar daily volatility (0.00).
RYLPF vs STSEY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $24.37, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas STSEY's P/E ratio is 39.41. In terms of profitability, RYLPF's ROE is +0.03%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, RYLPF and STSEY have similar daily volatility (0.00).
RYLPF vs VTRLY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $24.37, while VTRLY trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas VTRLY's P/E ratio is 38.21. In terms of profitability, RYLPF's ROE is +0.03%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, RYLPF and VTRLY have similar daily volatility (0.00).
RYLPF vs MCRPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, MCRPF has a market cap of 1.9B. Regarding current trading prices, RYLPF is priced at $24.37, while MCRPF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas MCRPF's P/E ratio is -8.67. In terms of profitability, RYLPF's ROE is +0.03%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, RYLPF and MCRPF have similar daily volatility (0.00).
RYLPF vs GGNDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $24.37, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas GGNDF's P/E ratio is 14.26. In terms of profitability, RYLPF's ROE is +0.03%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, RYLPF and GGNDF have similar daily volatility (0.00).
RYLPF vs DWRKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $24.37, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, RYLPF's ROE is +0.03%, compared to DWRKF's ROE of N/A. Regarding short-term risk, RYLPF and DWRKF have similar daily volatility (0.00).
RYLPF vs OSSUY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $24.37, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, RYLPF's ROE is +0.03%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, RYLPF and OSSUY have similar daily volatility (0.00).
RYLPF vs MEDGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $24.37, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, RYLPF and MEDGF have similar daily volatility (0.00).
RYLPF vs DRWKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, RYLPF is priced at $24.37, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas DRWKF's P/E ratio is 9.97. In terms of profitability, RYLPF's ROE is +0.03%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, RYLPF and DRWKF have similar daily volatility (0.00).
RYLPF vs DGWPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, RYLPF is priced at $24.37, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas DGWPF's P/E ratio is 7.81. In terms of profitability, RYLPF's ROE is +0.03%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, RYLPF and DGWPF have similar daily volatility (0.00).
RYLPF vs ELEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ELEAF has a market cap of 1B. Regarding current trading prices, RYLPF is priced at $24.37, while ELEAF trades at $12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ELEAF's P/E ratio is 14.38. In terms of profitability, RYLPF's ROE is +0.03%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, RYLPF and ELEAF have similar daily volatility (0.00).
RYLPF vs XVIPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, XVIPF has a market cap of 948.1M. Regarding current trading prices, RYLPF is priced at $24.37, while XVIPF trades at $30.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas XVIPF's P/E ratio is 65.43. In terms of profitability, RYLPF's ROE is +0.03%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, RYLPF and XVIPF have similar daily volatility (0.00).
RYLPF vs LFTSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, RYLPF is priced at $24.37, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, RYLPF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MDRSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, MDRSF has a market cap of 639.5M. Regarding current trading prices, RYLPF is priced at $24.37, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas MDRSF's P/E ratio is 151.47. In terms of profitability, RYLPF's ROE is +0.03%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, RYLPF and MDRSF have similar daily volatility (0.00).
RYLPF vs CLVSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, RYLPF is priced at $24.37, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, RYLPF and CLVSF have similar daily volatility (0.00).
RYLPF vs CALZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CALZF has a market cap of 531.9M. Regarding current trading prices, RYLPF is priced at $24.37, while CALZF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CALZF's P/E ratio is 77.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, RYLPF and CALZF have similar daily volatility (0.00).
RYLPF vs AVMR Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, RYLPF is priced at $24.37, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas AVMR's P/E ratio is -18.34. In terms of profitability, RYLPF's ROE is +0.03%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, RYLPF and AVMR have similar daily volatility (0.00).
RYLPF vs IOBCF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, IOBCF has a market cap of 414.5M. Regarding current trading prices, RYLPF is priced at $24.37, while IOBCF trades at $13.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas IOBCF's P/E ratio is 39.31. In terms of profitability, RYLPF's ROE is +0.03%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, RYLPF and IOBCF have similar daily volatility (0.00).
RYLPF vs HYBT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, RYLPF is priced at $24.37, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas HYBT's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, RYLPF and HYBT have similar daily volatility (0.00).
RYLPF vs EAPIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, EAPIF has a market cap of 349.5M. Regarding current trading prices, RYLPF is priced at $24.37, while EAPIF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas EAPIF's P/E ratio is -2.28. In terms of profitability, RYLPF's ROE is +0.03%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, RYLPF and EAPIF have similar daily volatility (0.00).
RYLPF vs CSSPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CSSPF has a market cap of 271.3M. Regarding current trading prices, RYLPF is priced at $24.37, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, RYLPF and CSSPF have similar daily volatility (0.00).
RYLPF vs CLLKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CLLKF has a market cap of 262.5M. Regarding current trading prices, RYLPF is priced at $24.37, while CLLKF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CLLKF's P/E ratio is -8.44. In terms of profitability, RYLPF's ROE is +0.03%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, RYLPF and CLLKF have similar daily volatility (0.00).
RYLPF vs CYBQY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CYBQY has a market cap of 257.9M. Regarding current trading prices, RYLPF is priced at $24.37, while CYBQY trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CYBQY's P/E ratio is -50.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, RYLPF and CYBQY have similar daily volatility (0.00).
RYLPF vs HTLZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, RYLPF is priced at $24.37, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, RYLPF's ROE is +0.03%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, RYLPF and HTLZF have similar daily volatility (0.00).
RYLPF vs BCCOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, RYLPF is priced at $24.37, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, RYLPF's ROE is +0.03%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, RYLPF and BCCOY have similar daily volatility (0.00).
RYLPF vs IMPZY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, RYLPF is priced at $24.37, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, RYLPF's ROE is +0.03%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, RYLPF and IMPZY have similar daily volatility (0.00).
RYLPF vs DMTRF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, DMTRF has a market cap of 193.2M. Regarding current trading prices, RYLPF is priced at $24.37, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, RYLPF and DMTRF have similar daily volatility (0.00).
RYLPF vs DTXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, RYLPF is priced at $24.37, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, RYLPF's ROE is +0.03%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, RYLPF and DTXMF have similar daily volatility (0.00).
RYLPF vs CYBQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, RYLPF is priced at $24.37, while CYBQF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, RYLPF and CYBQF have similar daily volatility (0.00).
RYLPF vs BRNHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, BRNHF has a market cap of 161.9M. Regarding current trading prices, RYLPF is priced at $24.37, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, RYLPF and BRNHF have similar daily volatility (0.00).
RYLPF vs PXMBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, PXMBF has a market cap of 154.5M. Regarding current trading prices, RYLPF is priced at $24.37, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, RYLPF's ROE is +0.03%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, RYLPF and PXMBF have similar daily volatility (0.00).
RYLPF vs EKDHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, EKDHF has a market cap of 152.7M. Regarding current trading prices, RYLPF is priced at $24.37, while EKDHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas EKDHF's P/E ratio is 17.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, RYLPF and EKDHF have similar daily volatility (0.00).
RYLPF vs BRSYF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, BRSYF has a market cap of 128.5M. Regarding current trading prices, RYLPF is priced at $24.37, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, RYLPF and BRSYF have similar daily volatility (0.00).
RYLPF vs VMTHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, RYLPF is priced at $24.37, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, RYLPF and VMTHF have similar daily volatility (0.00).
RYLPF vs AMEUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, RYLPF is priced at $24.37, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, RYLPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AVHHL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, AVHHL has a market cap of 115.6M. Regarding current trading prices, RYLPF is priced at $24.37, while AVHHL trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas AVHHL's P/E ratio is -1.83. In terms of profitability, RYLPF's ROE is +0.03%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, RYLPF and AVHHL have similar daily volatility (0.00).
RYLPF vs FDMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, RYLPF is priced at $24.37, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, RYLPF's ROE is +0.03%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, RYLPF and FDMDF have similar daily volatility (0.00).
RYLPF vs JMDMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, RYLPF is priced at $24.37, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, RYLPF's ROE is +0.03%, compared to JMDMF's ROE of N/A. Regarding short-term risk, RYLPF and JMDMF have similar daily volatility (0.00).
RYLPF vs SOMNF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SOMNF has a market cap of 92.1M. Regarding current trading prices, RYLPF is priced at $24.37, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SOMNF's P/E ratio is -14.20. In terms of profitability, RYLPF's ROE is +0.03%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, RYLPF and SOMNF have similar daily volatility (0.00).
RYLPF vs RSHUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, RYLPF is priced at $24.37, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, RYLPF's ROE is +0.03%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, RYLPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNZZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, SNZZF has a market cap of 86.1M. Regarding current trading prices, RYLPF is priced at $24.37, while SNZZF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas SNZZF's P/E ratio is -5.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, RYLPF and SNZZF have similar daily volatility (0.00).
RYLPF vs CKMTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, RYLPF is priced at $24.37, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, RYLPF's ROE is +0.03%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, RYLPF and CKMTF have similar daily volatility (0.00).
RYLPF vs IPDQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, IPDQF has a market cap of 66.9M. Regarding current trading prices, RYLPF is priced at $24.37, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas IPDQF's P/E ratio is -3.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, RYLPF is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BLOZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, BLOZF has a market cap of 53.8M. Regarding current trading prices, RYLPF is priced at $24.37, while BLOZF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas BLOZF's P/E ratio is -23.37. In terms of profitability, RYLPF's ROE is +0.03%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, RYLPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RDGL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, RDGL has a market cap of 52.5M. Regarding current trading prices, RYLPF is priced at $24.37, while RDGL trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas RDGL's P/E ratio is -11.57. In terms of profitability, RYLPF's ROE is +0.03%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, RYLPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TLTFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, TLTFF has a market cap of 41.6M. Regarding current trading prices, RYLPF is priced at $24.37, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas TLTFF's P/E ratio is -16.58. In terms of profitability, RYLPF's ROE is +0.03%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, RYLPF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NVYTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, RYLPF is priced at $24.37, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, RYLPF's ROE is +0.03%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, RYLPF and NVYTF have similar daily volatility (0.00).
RYLPF vs ELXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, RYLPF is priced at $24.37, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, RYLPF and ELXMF have similar daily volatility (0.00).
RYLPF vs MKEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, RYLPF is priced at $24.37, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, RYLPF and MKEAF have similar daily volatility (0.00).
RYLPF vs PLLWF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $24.37, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, RYLPF and PLLWF have similar daily volatility (0.00).
RYLPF vs KBBTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $24.37, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to KBBTF's ROE of N/A. Regarding short-term risk, RYLPF and KBBTF have similar daily volatility (0.00).
RYLPF vs POSC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, POSC has a market cap of 22.8M. Regarding current trading prices, RYLPF is priced at $24.37, while POSC trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas POSC's P/E ratio is 0.37. In terms of profitability, RYLPF's ROE is +0.03%, compared to POSC's ROE of +9.25%. Regarding short-term risk, RYLPF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EMITF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, EMITF has a market cap of 22.3M. Regarding current trading prices, RYLPF is priced at $24.37, while EMITF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas EMITF's P/E ratio is -14.36. In terms of profitability, RYLPF's ROE is +0.03%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, RYLPF and EMITF have similar daily volatility (0.00).
RYLPF vs MDXHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, MDXHF has a market cap of 19.8M. Regarding current trading prices, RYLPF is priced at $24.37, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, RYLPF's ROE is +0.03%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, RYLPF and MDXHF have similar daily volatility (0.00).
RYLPF vs ASAPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ASAPF has a market cap of 18.7M. Regarding current trading prices, RYLPF is priced at $24.37, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ASAPF's P/E ratio is -24.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, RYLPF and ASAPF have similar daily volatility (0.00).
RYLPF vs VPTDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, VPTDF has a market cap of 18.5M. Regarding current trading prices, RYLPF is priced at $24.37, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas VPTDF's P/E ratio is -5.55. In terms of profitability, RYLPF's ROE is +0.03%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, RYLPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GTHP Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, GTHP has a market cap of 18.1M. Regarding current trading prices, RYLPF is priced at $24.37, while GTHP trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas GTHP's P/E ratio is -4.60. In terms of profitability, RYLPF's ROE is +0.03%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, RYLPF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DIZTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, RYLPF is priced at $24.37, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, RYLPF's ROE is +0.03%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, RYLPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PYNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, PYNKF has a market cap of 16.6M. Regarding current trading prices, RYLPF is priced at $24.37, while PYNKF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas PYNKF's P/E ratio is -0.85. In terms of profitability, RYLPF's ROE is +0.03%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, RYLPF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RMSL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, RMSL has a market cap of 14.3M. Regarding current trading prices, RYLPF is priced at $24.37, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas RMSL's P/E ratio is 0.93. In terms of profitability, RYLPF's ROE is +0.03%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, RYLPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TMDIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, RYLPF is priced at $24.37, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, RYLPF's ROE is +0.03%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, RYLPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IMEXF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, RYLPF is priced at $24.37, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas IMEXF's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, RYLPF and IMEXF have similar daily volatility (0.00).
RYLPF vs ATBPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, RYLPF is priced at $24.37, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, RYLPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LXXGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, RYLPF is priced at $24.37, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, RYLPF's ROE is +0.03%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, RYLPF and LXXGF have similar daily volatility (0.00).
RYLPF vs ALRTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ALRTF has a market cap of 9.5M. Regarding current trading prices, RYLPF is priced at $24.37, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ALRTF's P/E ratio is -0.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, RYLPF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NGMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, NGMDF has a market cap of 9.1M. Regarding current trading prices, RYLPF is priced at $24.37, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas NGMDF's P/E ratio is -4.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, RYLPF and NGMDF have similar daily volatility (0.00).
RYLPF vs QLIS Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, RYLPF is priced at $24.37, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas QLIS's P/E ratio is 2.22. In terms of profitability, RYLPF's ROE is +0.03%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, RYLPF and QLIS have similar daily volatility (0.00).
RYLPF vs RHNMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, RYLPF is priced at $24.37, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, RYLPF's ROE is +0.03%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, RYLPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs FZMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, FZMD has a market cap of 5.2M. Regarding current trading prices, RYLPF is priced at $24.37, while FZMD trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas FZMD's P/E ratio is 1.40. In terms of profitability, RYLPF's ROE is +0.03%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, RYLPF and FZMD have similar daily volatility (0.00).
RYLPF vs VYCO Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, VYCO has a market cap of 4.4M. Regarding current trading prices, RYLPF is priced at $24.37, while VYCO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas VYCO's P/E ratio is -13.21. In terms of profitability, RYLPF's ROE is +0.03%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, RYLPF and VYCO have similar daily volatility (0.00).
RYLPF vs IRME Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, IRME has a market cap of 4.3M. Regarding current trading prices, RYLPF is priced at $24.37, while IRME trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas IRME's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to IRME's ROE of +11.77%. Regarding short-term risk, RYLPF is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TBRIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, TBRIF has a market cap of 4.1M. Regarding current trading prices, RYLPF is priced at $24.37, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas TBRIF's P/E ratio is -0.90. In terms of profitability, RYLPF's ROE is +0.03%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, RYLPF and TBRIF have similar daily volatility (0.00).
RYLPF vs LBLTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, RYLPF is priced at $24.37, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, RYLPF's ROE is +0.03%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, RYLPF and LBLTF have similar daily volatility (0.00).
RYLPF vs ADMT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ADMT has a market cap of 4M. Regarding current trading prices, RYLPF is priced at $24.37, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ADMT's P/E ratio is -5.97. In terms of profitability, RYLPF's ROE is +0.03%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, RYLPF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NUMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, NUMD has a market cap of 3.9M. Regarding current trading prices, RYLPF is priced at $24.37, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas NUMD's P/E ratio is 4.71. In terms of profitability, RYLPF's ROE is +0.03%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, RYLPF is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BIEL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, RYLPF is priced at $24.37, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas BIEL's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, RYLPF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VANIW Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, RYLPF is priced at $24.37, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas VANIW's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, RYLPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PMEDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, PMEDF has a market cap of 2.8M. Regarding current trading prices, RYLPF is priced at $24.37, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas PMEDF's P/E ratio is -1.46. In terms of profitability, RYLPF's ROE is +0.03%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, RYLPF and PMEDF have similar daily volatility (0.00).
RYLPF vs ODYY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ODYY has a market cap of 2.4M. Regarding current trading prices, RYLPF is priced at $24.37, while ODYY trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ODYY's P/E ratio is -0.17. In terms of profitability, RYLPF's ROE is +0.03%, compared to ODYY's ROE of +5.81%. Regarding short-term risk, RYLPF is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ESMC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, ESMC has a market cap of 2.4M. Regarding current trading prices, RYLPF is priced at $24.37, while ESMC trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas ESMC's P/E ratio is 6.47. In terms of profitability, RYLPF's ROE is +0.03%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs USAQ Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, USAQ has a market cap of 2.4M. Regarding current trading prices, RYLPF is priced at $24.37, while USAQ trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas USAQ's P/E ratio is -5.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, RYLPF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs KLYG Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, KLYG has a market cap of 1.4M. Regarding current trading prices, RYLPF is priced at $24.37, while KLYG trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas KLYG's P/E ratio is -11.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, RYLPF and KLYG have similar daily volatility (0.00).
RYLPF vs CYDX Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 23.1B. In comparison, CYDX has a market cap of 1.3M. Regarding current trading prices, RYLPF is priced at $24.37, while CYDX trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 81.22, whereas CYDX's P/E ratio is 0.33. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYDX's ROE of +0.17%. Regarding short-term risk, RYLPF and CYDX have similar daily volatility (0.00).